Arondite | $12,000,000 | (May 2, 2025)
SafeHeal | $39,548,022 | (May 2, 2025)
Ceto | $4,800,000 | (May 2, 2025)
Certified by Founder
Lodge
Tenvie Therapeutics
start up
United States
- South San Francisco, California
- 09/01/2025
- Unknown
- $200,000,000
Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function.
- Industry Biotechnology Research
- Website https://tenvie.com/
- LinkedIn https://www.linkedin.com/company/tenvie-therapeutics/
SatLeo Labs | $3,300,000 | (May 2, 2025)
Peek(US) | $5,000,000 | (May 2, 2025)
Paramark.com | $8,000,000 | (May 2, 2025)
Zoe Financial | $30,000,000 | (May 2, 2025)
Stately Bio | $12,000,000 | (May 2, 2025)
QbDVision | $13,000,000 | (May 2, 2025)
Blacksmith | $3,500,000 | (May 2, 2025)
Persona | $200,000,000 | (May 1, 2025)